Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Jun;40(6):1536–1541. doi: 10.1128/aac.40.6.1536

Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery.

T M Arain 1, A E Resconi 1, M J Hickey 1, C K Stover 1
PMCID: PMC163364  PMID: 8726034

Abstract

Bioluminescence-based assays to indicate antimicrobial susceptibility have been developed and validated for recombinant strains of Mycobacterium tuberculosis, Mycobacterium bovis BCG, Mycobacterium avium, and Mycobacterium intracellulare expressing an integrated eukaryotic luciferase gene. MICs determined with these bioluminescence assays for several antimycobacterial agents, including isoniazid, ethambutol, rifampin, amikacin, streptomycin, ciprofloxacin, and clarithromycin, compared favorably with traditional BACTEC methods and visual estimations of the inhibitory end point. Assay methodology has been optimized for the analysis of large numbers of novel compounds and is simple, inexpensive, and labor efficient. The availability of these four recombinant mycobacteria has permitted a strategy for drug discovery employing the nonpathogenic BCG strain for mass screening purposes with subsequent confirmation of activity against the pathogenic mycobacteria. Furthermore, evidence suggests that the BCG-based screen may allow the direct identification of bactericidal agents.

Full Text

The Full Text of this article is available as a PDF (256.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arain T. M., Resconi A. E., Singh D. C., Stover C. K. Reporter gene technology to assess activity of antimycobacterial agents in macrophages. Antimicrob Agents Chemother. 1996 Jun;40(6):1542–1544. doi: 10.1128/aac.40.6.1542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bates J. H. Tuberculosis chemotherapy. The need for new antituberculosis drugs is urgent. Am J Respir Crit Care Med. 1995 Apr;151(4):942–943. doi: 10.1164/ajrccm/151.4.942. [DOI] [PubMed] [Google Scholar]
  3. Beckers B., Lang H. R., Schimke D., Lammers A. Evaluation of a bioluminescence assay for rapid antimicrobial susceptibility testing of mycobacteria. Eur J Clin Microbiol. 1985 Dec;4(6):556–561. doi: 10.1007/BF02013394. [DOI] [PubMed] [Google Scholar]
  4. Conville P. S., Witebsky F. G., MacLowry J. D. Antimicrobial susceptibilities of mycobacteria as determined by differential light scattering and correlation with results from multiple reference laboratories. J Clin Microbiol. 1994 Jun;32(6):1554–1559. doi: 10.1128/jcm.32.6.1554-1559.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cooksey R. C., Crawford J. T., Jacobs W. R., Jr, Shinnick T. M. A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase. Antimicrob Agents Chemother. 1993 Jun;37(6):1348–1352. doi: 10.1128/aac.37.6.1348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cooksey R. C., Morlock G. P., Beggs M., Crawford J. T. Bioluminescence method to evaluate antimicrobial agents against Mycobacterium avium. Antimicrob Agents Chemother. 1995 Mar;39(3):754–756. doi: 10.1128/AAC.39.3.754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dolin P. J., Raviglione M. C., Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ. 1994;72(2):213–220. [PMC free article] [PubMed] [Google Scholar]
  8. Hickey M. J., Arain T. M., Shawar R. M., Humble D. J., Langhorne M. H., Morgenroth J. N., Stover C. K. Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice. Antimicrob Agents Chemother. 1996 Feb;40(2):400–407. doi: 10.1128/aac.40.2.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Inderlied C. B., Kemper C. A., Bermudez L. E. The Mycobacterium avium complex. Clin Microbiol Rev. 1993 Jul;6(3):266–310. doi: 10.1128/cmr.6.3.266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jacobs W. R., Jr, Barletta R. G., Udani R., Chan J., Kalkut G., Sosne G., Kieser T., Sarkis G. J., Hatfull G. F., Bloom B. R. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science. 1993 May 7;260(5109):819–822. doi: 10.1126/science.8484123. [DOI] [PubMed] [Google Scholar]
  11. Jacobs W. R., Jr, Kalpana G. V., Cirillo J. D., Pascopella L., Snapper S. B., Udani R. A., Jones W., Barletta R. G., Bloom B. R. Genetic systems for mycobacteria. Methods Enzymol. 1991;204:537–555. doi: 10.1016/0076-6879(91)04027-l. [DOI] [PubMed] [Google Scholar]
  12. Mahairas G. G., Sabo P. J., Hickey M. J., Singh D. C., Stover C. K. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol. 1996 Mar;178(5):1274–1282. doi: 10.1128/jb.178.5.1274-1282.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nilsson L. E., Hoffner S. E., Anséhn S. Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP. Antimicrob Agents Chemother. 1988 Aug;32(8):1208–1212. doi: 10.1128/aac.32.8.1208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Raviglione M. C., Snider D. E., Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA. 1995 Jan 18;273(3):220–226. [PubMed] [Google Scholar]
  15. Sarkis G. J., Jacobs W. R., Jr, Hatfull G. F. L5 luciferase reporter mycobacteriophages: a sensitive tool for the detection and assay of live mycobacteria. Mol Microbiol. 1995 Mar;15(6):1055–1067. doi: 10.1111/j.1365-2958.1995.tb02281.x. [DOI] [PubMed] [Google Scholar]
  16. Sarmientos P., Sylvester J. E., Contente S., Cashel M. Differential stringent control of the tandem E. coli ribosomal RNA promoters from the rrnA operon expressed in vivo in multicopy plasmids. Cell. 1983 Apr;32(4):1337–1346. doi: 10.1016/0092-8674(83)90314-8. [DOI] [PubMed] [Google Scholar]
  17. Siddiqi S. H., Heifets L. B., Cynamon M. H., Hooper N. M., Laszlo A., Libonati J. P., Lindholm-Levy P. J., Pearson N. Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates. J Clin Microbiol. 1993 Sep;31(9):2332–2338. doi: 10.1128/jcm.31.9.2332-2338.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stover C. K., de la Cruz V. F., Fuerst T. R., Burlein J. E., Benson L. A., Bennett L. T., Bansal G. P., Young J. F., Lee M. H., Hatfull G. F. New use of BCG for recombinant vaccines. Nature. 1991 Jun 6;351(6326):456–460. doi: 10.1038/351456a0. [DOI] [PubMed] [Google Scholar]
  19. Tomioka H., Sato K., Saito H. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs]. Kekkaku. 1991 Jul;66(7):489–492. [PubMed] [Google Scholar]
  20. Yamori S., Tsukamura M. Paradoxical effect of Tween 80 between the susceptibility to rifampicin and streptomycin and the susceptibility to ethambutol and sulfadimethoxine in the Mycobacterium avium-Mycobacterium intracellulare complex. Microbiol Immunol. 1991;35(10):921–926. doi: 10.1111/j.1348-0421.1991.tb02031.x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES